approval
saveHADLIMA (ADALIMUMAB-BWWD) — FDA approval
community read0 votes
Sponsor: SAMSUNG BIOEPIS CO LTD. Form: INJECTABLE. Route: INJECTION
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalHADLIMA (ADALIMUMAB-BWWD) — FDA approvalJun 23, 2025 · 468d ago
- approvalHADLIMA (ADALIMUMAB-BWWD) — FDA approvalMay 21, 2025 · 501d ago
- approvalHADLIMA (ADALIMUMAB-BWWD) — FDA approvalMay 21, 2025 · 501d ago
- approvalHADLIMA (ADALIMUMAB-BWWD) — FDA approvalJun 28, 2024 · 828d ago
- approvalHADLIMA (ADALIMUMAB-BWWD) — FDA approvalJul 11, 2023 · 1181d ago
- approvalHADLIMA (ADALIMUMAB-BWWD) — FDA approvalJun 26, 2023 · 1196d ago
- approvalHADLIMA (ADALIMUMAB-BWWD) — FDA approvalApr 26, 2023 · 1257d ago
- approvalHADLIMA (ADALIMUMAB-BWWD) — FDA approvalDec 23, 2022 · 1381d ago
same company · ±60 days · 6
- approvalinfliximab biosimilar: RENFLEXIS (INFLIXIMAB-ABDA) — FDA approvalOct 28, 2025
- approvaldenosumab biosimilar: DENOSUMAB-DSSB — FDA approvalOct 29, 2025
- recallSamsung Bioepis Co., Ltd. recall (Cls II)Nov 5, 2025
- approvalEPYSQLI: EPYSQLI (ECULIZUMAB-AAGH) — FDA approvalNov 10, 2025
- approvalBYOOVIZ: BYOOVIZ (RANIBIZUMAB-NUNA) — FDA approvalNov 12, 2025
- approvalPYZCHIVA: PYZCHIVA (USTEKINUMAB-TTWE) — FDA approvalNov 18, 2025
comments(0)
5-min edit window · permanent after that